Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cluster, facets, and edges: site-dependent selective chemistry on model catalysts.

Chemical record (New York, N.Y.)·2003

Same author

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.

Current drug targets. CNS and neurological disorders·2003

Same author

Noonan's syndrome and autoimmune diseases.

Journal of pediatric endocrinology & metabolism : JPEM·2003

Same author

Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1.

Neurology·2002

Same author

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

Bioscience reports·2002

Same author

Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems.

Journal of neural transmission (Vienna, Austria : 1996)·2002

Same journal

Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

Clinical pharmacology and therapeutics·2026

Same journal

Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

Clinical pharmacology and therapeutics·2026

Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026

Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026

Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026

Same journal

Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient".

Clinical pharmacology and therapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

R L Grossman¹, B Abel², S Angiuoli³

¹Center for Data Intensive Science, University of Chicago, Chicago, Illinois, USA.

Clinical Pharmacology and Therapeutics

|February 11, 2017

Summary

This summary is machine-generated.

The Blood Profiling Atlas in Cancer (BloodPAC) Project aims to accelerate cancer blood test development. It will share harmonized data and protocols to improve cancer assessment and monitoring.

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Experiment Videos

Last Updated: Mar 7, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

Oncology
Biotechnology
Genomics

Background:

Blood profiling measurements are crucial for cancer assessment and monitoring.
The development of blood profiling assays is essential for advancing cancer care.

Purpose of the Study:

To describe the Blood Profiling Atlas in Cancer (BloodPAC) Project.
To outline BloodPAC's strategy for aggregating and harmonizing data to accelerate assay development.

Main Methods:

Collaborative effort involving academic, government, and industry partners.
Aggregation and harmonization of raw datasets, clinical data, and protocols.
Making data freely available for analysis.

Main Results:

Establishment of a multi-stakeholder project (BloodPAC).
Creation of a freely accessible, harmonized dataset for blood profiling.
Development of standardized protocols for sample preparation and handling.

Conclusions:

The BloodPAC Project will accelerate the development of blood profiling assays.
Improved blood profiling assays will enhance cancer assessment and monitoring.
Data sharing and harmonization are key to advancing cancer diagnostics.